Redhill Biopharma Ltd.

RDHL·NASDAQ·$1.01Share Price as of 11/2·$3MMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)04/27/26 20-FAnnual report (foreign)04/10/25 20-FAnnual report (foreign)04/08/24 20-FAnnual report (foreign)04/28/23 20-FAnnual report (foreign)03/17/22

Disclosures

6-KForeign issuer report10/21/26 6-KForeign issuer report10/19/26 6-KForeign issuer report10/13/26 6-KForeign issuer report10/07/26 6-KForeign issuer report09/30/26

Prospectuses and Registrations

424B5Prospectus supplement10/13/26 424B3Prospectus07/14/26 F-3Shelf registration (foreign)07/02/26 424B5Prospectus supplement06/29/26 424B5Prospectus supplement05/07/26

Proxies

No matching filings.

Ownership

Form 4Insider transaction10/06/26 Form 4Insider transaction07/13/26 Form 4Insider transaction04/22/26 Form 3Initial insider ownership03/19/26 Form 3Initial insider ownership03/18/26

Other

EFFECTRequest for effectiveness07/13/26 EFFECTRequest for effectiveness05/05/26 EFFECTRequest for effectiveness01/27/26 CORRESPCorrespondence with the SEC01/26/26 UPLOADLetter from the SEC01/06/26